VT7208
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VT7208, covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients [Phase 1, Phase 2]